| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,291 |
4,030 |
$158K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
652 |
433 |
$21K |
| 87428 |
|
263 |
240 |
$13K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
244 |
193 |
$11K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
557 |
464 |
$5K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
54 |
38 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
139 |
81 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
13 |
12 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
95 |
62 |
$742.39 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
45 |
43 |
$647.72 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
20 |
12 |
$9.02 |
| 3008F |
|
27 |
12 |
$0.00 |